(1-Cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

Catalog No. :
ACSPHJ701
CAS No. :
2304634-13-5
Molecular Formula :
C9H12BF3N2O2
Molecular Weight :
248.01

IUPAC Name:(1-cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

(1-Cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$71.00Login to see priceIn stockInquiry
250mg95%$117.00Login to see priceIn stockInquiry
1g95%$291.00Login to see priceIn stockInquiry
5g95%$960.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid
IUPAC Name(1-cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid
MDL No.MFCD25953899
Molecular FormulaC9H12BF3N2O2
Molecular Weight248.01
SMILESFC(C1=NN(C2CCCC2)C=C1B(O)O)(F)F
InChI KeyJFERHZBESSKOMR-UHFFFAOYSA-N
Synonym1-Cyclopentyl-3-(trifluoroMethyl)pyrazole-4-boronic acid;Boronic acid, B-[1-cyclopentyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-;1-cyclopentyl-3-(trifluoromethyl)pyrazol-4-yl]boronic acid
CAS No.2304634-13-5
PubChem CID74892362

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSPHJ701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSPHJ701 route product structure diagram
    ACSPHJ7012304634-13-5 In Stock
Inquiry

2. ACSPHJ701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLCKZ561 route compound structure diagram
    ACLCKZ5611202054-12-3 In Stock
  4. Then
  5. ACSPHJ701 route product structure diagram
    ACSPHJ7012304634-13-5 In Stock
Inquiry

Comments (0)